Stockhead
 
Closing Bell: US-China trade talks push up ASX as energy stocks ride oil price higher

Closing Bell: US-China trade talks push up ASX as energy stocks ride oil price higher

Renewed US-China trade talks and strong movements in the Energy sector have lifted the ASX 0.33pc.

 
Resources Top 5: Yari Minerals a prime mover on Bowen Basin coal project acquisition

Resources Top 5: Yari Minerals a prime mover on Bowen Basin coal project acquisition

Yari Minerals has diversified its Australian asset base to include the Rolleston South coal project, an advanced play with a resource and near-term development potential.

 
Time for Anthony Albanese to get serious on AI, say tech bosses

Time for Anthony Albanese to get serious on AI, say tech bosses

Following Labor’s resounding election victory, the nation’s tech leaders have implored the government to take advantage of the opportunity AI offers it to boost lagging productivity.

 
Medallion Metals eyes greater mine life after extending high-grade gold lode

Medallion Metals eyes greater mine life after extending high-grade gold lode

Resource growth could be on the cards after Medallion Metals’ drilling extended the high-grade gold lode at Gem deposit.

 
Health Check: It’s sale time as Medadvisor mulls Aussie exit and Althea renounces medicinal cannabis

Health Check: It’s sale time as Medadvisor mulls Aussie exit and Althea renounces medicinal cannabis

Medadvisor shares today soared up to 60% after the company said it had found a tentative buyer for its Australian pharmacy business.

 

EDITOR'S MUST READS OF THE DAY

 
Biocurious: With psychedelic therapies gaining cred, Tryptamine offers patients and investors the trip of a lifetime

Biocurious: With psychedelic therapies gaining cred, Tryptamine offers patients and investors the trip of a lifetime

In a world first, Tryptamine Therapeutics is using intravenously delivered psilocybin in a binge-eating disorder clinical trial.